Fmoc-L-Dap(Dde)-OH

Fmoc-L-Dap(Dde)-OH is an Fmoc-protected, stereodefined amino acid derivative featuring L-2,3-diaminopropanoic acid (L-Dap) bearing a Dde-protected side-chain amino group, with the alpha-amino and alpha-carboxyl functions incorporated into the amino acid framework. The molecule contains an N-terminal 9H-fluoren-9-ylmethoxycarbonyl (Fmoc) protecting group on the alpha-amino group and an N-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl) (Dde) protecting group on the side-chain amino, providing orthogonal protection that suppresses undesired amine reactivity during stepwise assembly. Fmoc-L-Dap(Dde)-OH is used as a protected building block for peptide synthesis and for preparing peptides or peptide-related intermediates in which the side-chain amino of Dap is introduced in a controlled, chemoselective manner for subsequent functionalization or conjugation.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP25654

CAS No:247127-51-1

Synonyms/Alias:247127-51-1;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)amino)propanoic acid;fmoc-(n-beta-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl)-l-alpha,beta-diaminopropionic acid;AmbotzFAA1462;SCHEMBL14628067;CTK8E9967;MolPort-006-705-615;8298AD;AKOS022184288;ZINC100140898;RTR-061859;AJ-95462;AK-88066;TR-061859;FT-0696171;A-8187;I04-1263;I14-15383;Na-Fmoc-Nb-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-2,3-diaminopropionic acid;(2S)-3-{[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino}-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}propanoic acid;N-(9H-Fluorene-9-ylmethoxycarbonyl)-3-[1-(2,6-dioxo-4,4-dimethylcyclohexylidene)ethylamino]-L-alanine;Fmoc-Dap(Dde)-OH;fmoc-(n-beta-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl)-l-alpha,beta-diaminopropionic acid;L-Alanine, 3-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)ethylideneamino]propanoic acid;MFCD01631974;(2S)-3-{[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino}-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}propanoic acid;SCHEMBL14628067;DTXSID00673970;AKOS022184288;AS-74884;CS-0101006;N-alpha-Fmoc-N-beta-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-2,3-diaminopropionic acid;3-{[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]amino}-N-{[(9H-fluoren-9-yl)methoxy]carbonyl}-L-alanine;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-beta-[(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-2,3-diaminopropionic acid

Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-beta-[(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-2,3-diaminopropionic acid

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C28H30N2O6
M.W/Mr.
490,56 g/mole

Fmoc-L-Dap(Dde)-OH is an Fmoc-protected, stereodefined lysine-like amino acid derivative featuring the L-configuration at the alpha carbon and a side-chain protected diaminopropyl motif. The side-chain bears a Dde (1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl) protecting group on the amino functionality, enabling selective deprotection under conditions compatible with many peptide synthesis workflows. The molecule contains an activated carboxylic acid for amide bond formation and an orthogonally protected amine that can be unveiled late in synthesis for targeted functionalization. The combination of Fmoc and Dde protection provides controlled reactivity of both the backbone nitrogen and the side-chain amine, supporting peptide building block use and downstream derivatization into conjugatable or crosslinkable intermediates.

1. Peptide Synthesis

Fmoc-L-Dap(Dde)-OH is applied in solid-phase peptide synthesis where the Fmoc group supports stepwise N-terminal protection and coupling, while the Dde-protected side-chain amine remains masked during earlier chain elongation. The alpha-carboxylic acid and Fmoc-protected amino nitrogen enable standard peptide coupling chemistry to incorporate the L-Dap residue as a lysine-analog with orthogonally addressable functionality. Side-chain deprotection after chain assembly can generate a free primary amine for subsequent on-resin modifications such as acylation, alkylation, or attachment of linkers. The resulting peptide products can be used as research-grade scaffolds for studying amine-mediated interactions, crosslinking behavior, and sequence-dependent properties in peptide science and peptide analog development.

2. Bioconjugation Chemistry

Fmoc-L-Dap(Dde)-OH serves as a chiral, orthogonally protected amino acid intermediate for preparing peptides and peptide-like conjugates that require controlled installation of a primary amine handle. The Dde group on the side-chain enables late-stage exposure of the amine, which can then participate in amide bond formation, urea/thiourea formation, reductive amination, or nucleophilic substitution strategies used in conjugation workflows. The Fmoc functionality supports incorporation into peptide backbones that present the side-chain amine at a defined spatial position, improving reproducibility of labeling or coupling chemistry. Downstream derivatives such as amine-functionalized peptide conjugates can be used in chemical biology research and as manufacturing intermediates for biomolecule labeling reagents.

3. Side-Chain Functionalization

Fmoc-L-Dap(Dde)-OH is suitable for side-chain functionalization routes where orthogonal protection controls chemoselectivity between backbone and side-chain nitrogens. The Dde-protected primary amine can be unmasked to generate a nucleophilic handle for introducing functional groups such as activated esters, carbamates, sulfonamides, or heteroatom-containing substituents that tune solubility and reactivity. The stereodefined L-Dap residue provides a predictable geometry relative to the peptide backbone, supporting structure-function studies that correlate side-chain modifications with binding, stability, or processing behavior. The protected amino acid derivative can also function as a process chemistry intermediate for generating defined amine-bearing building blocks used in fine chemical synthesis and peptide analog construction.

4. Drug Discovery SAR Studies

Fmoc-L-Dap(Dde)-OH is used in medicinal chemistry and SAR-focused peptide and peptidomimetic design to introduce a lysine-like side-chain that can be systematically varied after peptide assembly. The orthogonal Fmoc/Dde protection strategy supports iterative synthesis of analog series where the side-chain amine is revealed at a controlled stage for diversification into acylated, alkylated, or conjugated variants. The presence of a stereodefined alpha center helps maintain consistent conformational preferences across analogs, which is important when comparing structure-activity relationship outcomes driven by side-chain chemistry. The resulting modified peptide scaffolds and intermediates can be employed for binding studies, assay development, and generation of structure-defined libraries for downstream discovery workflows.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-Dap(Dde)-OH can be incorporated into manufacturing-oriented peptide intermediate preparation where orthogonally protected amines support robust, scalable synthesis planning. The Fmoc group provides a reliable mechanism for N-terminal deprotection during chain assembly, while the Dde-protected side-chain amine supports controlled late-stage functionalization without interfering with earlier coupling steps. The carboxylic acid functionality enables conversion into peptide-coupling-ready intermediates aligned with industrial peptide synthesis practices, including the preparation of defined amine-bearing fragments. The ability to generate consistent, side-chain-addressable peptide intermediates supports downstream production of functional peptide materials used in research reagent manufacturing, specialty chemical production, and applied peptide-based process development.

Size
1 g;5 g;25 g;
InChI
1S/C28H30N2O6/c1-16(25-23(31)12-28(2,3)13-24(25)32)29-14-22(26(33)34)30-27(35)36-15-21-19-10-6-4-8-17(19)18-9-5-7-11-20(18)21/h4-11,21-22,29H,12-15H2,1-3H3,(H,30,35)(H,33,34)/t22-/m0/s1
InChI Key
IGNPBNCBFYUHTM-QFIPXVFZSA-N
Canonical SMILES
CC(=C1C(=O)CC(CC1=O)(C)C)NCC(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide Modification ServicesPeptide CDMOEpitope Mapping ServicesPeptide Analysis ServicesPeptide Nucleic Acids SynthesisCustom Conjugation ServicePeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers